---
title: CRO Daily News — October 12, 2026
slug: daily-news-2026-10-12-cro
site: cro
post_kind: news
byline: BioBM
description: October 12 CRO daily: EMA's ACT EU Clinical Trial Advice Pilot Becomes Permanent in January 2027 — CRO regulatory and trial-management teams can now plan…
canonical_url: https://www.cro.directory/posts/daily-news-2026-10-12-cro
published_at: 2026-10-12T23:59:46.080Z
last_updated: 2026-10-13T00:00:48.933Z
---

### EMA's ACT EU Clinical Trial Advice Pilot Becomes Permanent in January 2027
- The Accelerating Clinical Trials in the EU (ACT EU) advice pilot, which provides pre-submission regulatory and technical guidance to trial sponsors, will transition to a permanent program starting January 2027.
- Since launch in 2024, the pilot has processed approximately 30 applications, delivering consolidated multi-Member State feedback that improves application quality and accelerates EMA assessment timelines.
- Updated guidance documents and templates will be published in January 2027 to support sponsors navigating the EU clinical trials framework under the permanent initiative.

**Operational Impact**

CRO regulatory and trial-management teams can now plan sustained engagement with EMA's consolidated pre-submission advice process, reducing application rework cycles and improving first-submission acceptance rates across EU trials.

*Source: [EMA News and Press RSS](https://www.ema.europa.eu/en/news/clinical-trial-applications-advice-pilot-becomes-permanent)*

## References

1. [EMA News and Press RSS — EMA's ACT EU Clinical Trial Advice Pilot Becomes Permanent in January 2027](https://www.ema.europa.eu/en/news/clinical-trial-applications-advice-pilot-becomes-permanent)

Source: https://www.cro.directory/posts/daily-news-2026-10-12-cro